SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck
MRK 108.83-1.9%Jan 16 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: songw who wrote (603)3/2/1998 8:26:00 PM
From: LWolf  Read Replies (1) of 1580
 
Hi songw, read the article on AVAX Technologies (AVXT)anti-cancer vaccines. Sounds like they are doing wonderful things.

Not aware of any connection to Merck.

My initial reaction is that this news will probably help put more money into AVXT's stock, but until these new methods go through phase trials and get FDA approvals they aren't marketable. I noticed that there are several news items dating back into November stating how AVAX Technologies is planing to work with FDA with various vaccines for fighting cancer.

As much as I think this may have wonderful possibilities for cancer treatment, my own knowledge of the various approaches for attacking cancer is nil. My reaction right now is skeptical.... because it generally takes so long to get these treatments approved.

My next reaction is that the major pharmaceuticals are probably watching this, and if they see strong potential with the technique one will make a buyout bid.

Laura
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext